首页|miR-146a、miR-23b水平与前列腺癌患者术前临床分期及预后的关系

miR-146a、miR-23b水平与前列腺癌患者术前临床分期及预后的关系

扫码查看
目的 探索miR-146a、miR-23b表达水平与前列腺癌(PCa)患者术前临床分期及预后的关系.方法 选取2019年3月-2020年3月期间重庆市丰都县人民医院收治的70例PCa患者和70例良性前列腺增生症(BPH)患者,设为PCa组和BPH组,入组后分别进行前列腺组织取样,检测两组前列腺中miR-146a、miR-23b表达水平,分析miR-146a、miR-23b表达与PCa患者临床病理特征及预后的相关性.结果 PCa组miR-146a、miR-23b表达低于BPH组,差异有统计学意义(P<0.05);术前PCa患者miR-146a、miR-23b水平随Gleason评分和临床T分期升高而逐次下降(P<0.05);PCa患者术前存在淋巴结转移者miR-146a、miR-23b水平低于无转移者,差异有统计学意义(P<0.05);Spearman相关性分析结果显示,PCa患者术前前列腺组织miR-146a、miR-23b表达水平分别与临床分期呈现负相关(r=-0.758、-0.760,均P<0.05);截止随访,预后不良的PCa患者miR-146a、miR-23b低于预后良好组,差异有统计学意义(P<0.05);miR-146a、miR-23b联合检测预测PCa预后AUC高于单一检测指标(P<0.05).结论 PCa患者前列腺组织中miR-146a、miR-23b表达较低,且与临床分期相关,miR-146a、miR-23b表达水平对患者不良预后有一定预测价值.
Relationship between miR-146a and miR-23b levels and preoperative clinical staging and prognosis in patients with prostate cancer
Objective To explore the relationship between miR-146a,miR-23b and preoperative clinical staging,prognosis of patients with prostate cancer(PCa).Methods A total of 70 patients with PCa and 70 patients with benign prostatic hyperplasia(BPH)at Fengdu County People's Hospital in Chongqing were enrolled in the PCa group and the BPH group between March 2019 and March 2020.All patients under-went prostate tissue sampling.The expression levels of miR-146a and miR-23b in the prostate were detected,and their correlation with clinicopathological characteristics and the prognosis of PCa patients were analyzed.Results The expression levels of miR-146a and miR-23b in the PCa group were lower than those in the BPH group(P<0.05).The levels of miR-146a and miR-23b decreased with the increase of Gleason score and clinical T staging(P<0.05).The expression levels of miR-146a and miR-23b in PCa patients with lymph node metasta-sis were lower than those without lymph node metastasis(P<0.05).The results of Spearman correlation analysis showed that the expression levels of miR-146a and miR-23b were negatively correlated with clinical staging(r=-0.758,-0.760,P<0.05).By the end of follow-up,the expression levels of miR-146a and miR-23b in PCa pa-tients with a poor prognosis were lower than those with a good prognosis(P<0.05).The AUC of miR-146a com-bined with miR-23b for predicting the prognosis of PCa was greater than that of a single index(P<0.05).Conclusion The levels of miR-146a and miR-23b expression in prostate tissues are low in PCa patients.These levels are correlated with clinical staging and have predictive value for poor prognosis.

MiR-146aMiR-23bProstate cancerBenign prostatic hyperplasia

张宇、王宏权、李俞润、袁刚军

展开 >

重庆市丰都县人民医院泌尿外科,重庆 408200

重庆大学附属肿瘤医院泌尿外科,重庆 408200

miR-146a miR-23b 前列腺癌 良性前列腺增生

丰都县科技计划

FD2022-18

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(4)
  • 18